The program provides ongoing consultation and monitoring by an RDN and physician and aims to promote healthy weight loss, balance blood sugar levels, and teach long-term maintenance through healthy lifestyle habits
NDA filing is widely expected Q4 2026
Primary care physicians will likely need education and training focused on this new class of medications, given a shortage of endocrinologists and obesity medicine specialists. Lee and colleagues noted there were study limitations, such as a lack of data on prescription indication, including whether it was used off-label. However, the increase in dispensing of injectable semaglutide for weight management suggests increasing use for this indication, they wrote
Shower with a 4% CHG solution antiseptic skin cleanser, such as Hibiclens Shower with a 4% CHG solution antiseptic skin cleanser before you leave for the hospital
While orforglipron is a huge strategic story for 2026, Mounjaro and Zepbound are still more likely to drive the biggest absolute revenue gains this year